bioAffinity Technologies (BIAF) Competitors $0.76 -0.01 (-1.88%) Closing price 01/31/2025 03:59 PM EasternExtended Trading$0.76 0.00 (0.00%) As of 01/31/2025 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BIAF vs. PIXY, VIVK, MNY, BTCM, ISDR, KPLT, AERT, SJ, SCOR, and GFAIShould you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include ShiftPixy (PIXY), Vivakor (VIVK), MoneyHero (MNY), BIT Mining (BTCM), Issuer Direct (ISDR), Katapult (KPLT), Aeries Technology (AERT), Scienjoy (SJ), comScore (SCOR), and Guardforce AI (GFAI). These companies are all part of the "business services" industry. bioAffinity Technologies vs. ShiftPixy Vivakor MoneyHero BIT Mining Issuer Direct Katapult Aeries Technology Scienjoy comScore Guardforce AI bioAffinity Technologies (NASDAQ:BIAF) and ShiftPixy (NASDAQ:PIXY) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings, dividends and community ranking. Does the media refer more to BIAF or PIXY? In the previous week, bioAffinity Technologies had 2 more articles in the media than ShiftPixy. MarketBeat recorded 2 mentions for bioAffinity Technologies and 0 mentions for ShiftPixy. bioAffinity Technologies' average media sentiment score of 0.44 beat ShiftPixy's score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the media. Company Overall Sentiment bioAffinity Technologies Neutral ShiftPixy Neutral Do institutionals and insiders believe in BIAF or PIXY? 1.6% of bioAffinity Technologies shares are held by institutional investors. Comparatively, 1.5% of ShiftPixy shares are held by institutional investors. 35.1% of bioAffinity Technologies shares are held by company insiders. Comparatively, 63.3% of ShiftPixy shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has stronger earnings & valuation, BIAF or PIXY? bioAffinity Technologies has higher earnings, but lower revenue than ShiftPixy. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiobioAffinity Technologies$2.53M4.68-$7.94M-$0.82-0.93ShiftPixy$15.02M2.94-$33.63MN/AN/A Which has more risk & volatility, BIAF or PIXY? bioAffinity Technologies has a beta of 2.98, indicating that its stock price is 198% more volatile than the S&P 500. Comparatively, ShiftPixy has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Does the MarketBeat Community believe in BIAF or PIXY? ShiftPixy received 109 more outperform votes than bioAffinity Technologies when rated by MarketBeat users. However, 100.00% of users gave bioAffinity Technologies an outperform vote while only 68.32% of users gave ShiftPixy an outperform vote. CompanyUnderperformOutperformbioAffinity TechnologiesOutperform Votes1100.00% Underperform VotesNo VotesShiftPixyOutperform Votes11068.32% Underperform Votes5131.68% Do analysts prefer BIAF or PIXY? bioAffinity Technologies currently has a consensus target price of $6.00, suggesting a potential upside of 689.47%. Given bioAffinity Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe bioAffinity Technologies is more favorable than ShiftPixy.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score bioAffinity Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00ShiftPixy 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is BIAF or PIXY more profitable? bioAffinity Technologies has a net margin of -91.22% compared to ShiftPixy's net margin of -197.48%. ShiftPixy's return on equity of 0.00% beat bioAffinity Technologies' return on equity.Company Net Margins Return on Equity Return on Assets bioAffinity Technologies-91.22% -205.09% -115.95% ShiftPixy -197.48%N/A -515.10% SummarybioAffinity Technologies beats ShiftPixy on 12 of the 16 factors compared between the two stocks. Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIAF vs. The Competition Export to ExcelMetricbioAffinity TechnologiesCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.16M$4.17B$5.58B$9.11BDividend YieldN/A1.88%5.32%3.99%P/E Ratio-0.9353.7989.2618.26Price / Sales4.68110.651,254.4080.65Price / CashN/A22.8945.9637.70Price / Book1.493.285.124.70Net Income-$7.94M$139.50M$111.40M$224.47M7 Day Performance7.03%0.28%2.33%-0.20%1 Month Performance-16.48%8.02%3.20%0.57%1 Year Performance-50.65%-1.40%24.64%20.29% bioAffinity Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIAFbioAffinity Technologies2.6287 of 5 stars$0.76-1.9%$6.00+689.5%-51.6%$12.16M$2.53M-0.9310Short Interest ↑PIXYShiftPixyN/A$6.53flatN/AN/A$44.12M$15.02M0.0060VIVKVivakor0.4756 of 5 stars$1.05-3.7%N/A+2.1%$43.06M$61.99M-2.4420Short Interest ↑Gap DownMNYMoneyHero1.6246 of 5 stars$1.09-0.9%N/A+8.1%$42.01M$80.67M-0.33359Short Interest ↓BTCMBIT Mining0.6121 of 5 stars$2.70-4.8%N/A-33.1%$40.75M$43.10M-2.06150Short Interest ↓Positive NewsGap UpISDRIssuer DirectN/AN/AN/AN/A$39.01M$29.14M-29.07140Analyst ForecastNews CoverageGap UpHigh Trading VolumeKPLTKatapult2.8401 of 5 stars$8.75-4.0%$12.00+37.1%-14.9%$38.42M$241.79M-1.06130Options VolumePositive NewsGap DownAERTAeries Technology1.9039 of 5 stars$0.78-1.5%N/A-72.7%$34.62M$72.51M1.661,700Short Interest ↓News CoverageGap UpSJScienjoy2.393 of 5 stars$0.87+1.6%N/A-75.8%$33.67M$206.32M5.46280Short Interest ↓Positive NewsSCORcomScore2.5483 of 5 stars$6.87-3.9%$10.75+56.5%-62.9%$33.59M$371.34M-0.321,250GFAIGuardforce AI0.6592 of 5 stars$1.62-12.0%N/A-35.4%$32.77M$35.84M0.001,594Short Interest ↑News CoverageGap Up Related Companies and Tools Related Companies ShiftPixy Competitors Vivakor Competitors MoneyHero Competitors BIT Mining Competitors Issuer Direct Competitors Katapult Competitors Aeries Technology Competitors Scienjoy Competitors comScore Competitors Guardforce AI Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BIAF) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredNew catalyst on Wall Street’s radar for this week (NOT Trump)Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger ...Timothy Sykes | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIAF Stock Alerts